Relevant bibliographies by topics / Breast Cancer Patients Counseling of

Academic literature on the topic 'Breast Cancer Patients Counseling of'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Breast Cancer Patients Counseling of.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Breast Cancer Patients Counseling of"

1

Monnin, Suzanne, and M. Rosita Schiller. "Nutrition counseling for breast cancer patients." Journal of the American Dietetic Association 93, no. 1 (January 1993): 72–73. http://dx.doi.org/10.1016/0002-8223(93)92136-l.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Powell, C. Bethan, Ramey Littell, Elizabeth Hoodfar, Fiona Sinclair, and Alice Pressman. "Does the Diagnosis of Breast or Ovarian Cancer Trigger Referral to Genetic Counseling?" International Journal of Gynecologic Cancer 23, no. 3 (March 2013): 431–36. http://dx.doi.org/10.1097/igc.0b013e318280f2b4.

Full text
Abstract:
ObjectiveKaiser Permanente Northern California is a large integrated health care delivery system in the United States that has guidelines for referring women with newly diagnosed BRCA1-and BRCA2-associated cancers for genetic counseling. This study assesses adherence to genetic counseling referral guidelines within this health system.MethodsChart review was performed to identify patients with cancer who met the following pathology-based Kaiser Permanente Northern California guidelines for referral for genetic counseling: invasive breast cancer, younger than age 40; nonmucinous epithelial ovarian, fallopian tube, or peritoneal cancer, younger than age 60; women with synchronous or metachronous primary cancers of the breast and ovaries; and male breast cancer. We assessed compliance with referral guidelines. An electronic notice was sent to the managing physician of patients with newly diagnosed cancer to assess the feasibility of this intervention.ResultsA total of 340 patients were identified with breast cancer at younger than age 40 or with ovarian, peritoneal, or tubal cancer between January and June, 2008. Upon chart review, 105 of these patients met pathology-based criteria for referral to genetic counseling, of whom 47 (45%) were referred within the 2-year study period. Of the 67 subjects with breast cancer, 40 subjects (60%) were referred. In contrast, only 7 (21%) of 33 patients with ovarian cancer were referred (P < 0.001). A pilot study was performed to test the feasibility of notifying managing oncologists with an electronic letter alerting them of eligibility for genetic referral of patients with new diagnosis (n = 21). In the 3 to 6 months after this notification, 12 of these 21 patients were referred for counseling including 5 of 7 patients with a diagnosis of ovarian cancer.ConclusionThere is a missed opportunity for referring patients to genetic counseling, especially among patients with ovarian cancer. A pilot study suggests that alerting treating physicians is a feasible strategy to increase appropriate referral.
APA, Harvard, Vancouver, ISO, and other styles
3

Kroupis, C., E. Lianidou, N. Goutas, S. Vasilaros, D. Yannoukakos, and M. B. Petersen. "Genetic counseling of medullary breast cancer patients." Clinical Genetics 65, no. 4 (March 12, 2004): 343–44. http://dx.doi.org/10.1111/j.1399-0004.2003.00231.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lee, Siwon, Amal Gedleh, Jessica A. Hill, Seemi Qaiser, Yvonne Umukunda, Philip Odiyo, Grace Kitonyi, and Helen Dimaras. "In Their Own Words: A Qualitative Study of Kenyan Breast Cancer Survivors’ Knowledge, Experiences, and Attitudes Regarding Breast Cancer Genetics." Journal of Global Oncology, no. 4 (December 2018): 1–9. http://dx.doi.org/10.1200/jgo.17.00061.

Full text
Abstract:
Introduction Breast cancer ranks among the most common adult cancers in Kenya. Individuals with a family history of the disease are at increased risk. Mutations most commonly associated with breast cancer affect BRCA1 and BRCA2; mutations in several other genes may also confer breast cancer risk. Genetic testing and counseling can help patients understand their risk and assist clinicians in choosing therapies. We aimed to uncover what patients know, experience, and think with regard to breast cancer genetics in Kenya. Methods Participants included breast cancer survivors age > 18 years. Participants completed a demographic questionnaire before participating in focus group discussions to uncover knowledge of, experiences with, and attitudes toward the genetics of breast cancer. Data were analyzed by inductive thematic analysis. Results Four focus groups were conducted. Participants had rudimentary knowledge about genetics and cancer development, and although they understood breast cancer could be familial, many suspected environmental factors causing spontaneous disease. They reported limited experience with counseling about genetic risk, perceiving that their physicians were too busy to provide comprehensive information. Many indicated they promoted cancer screening among family to promote early diagnosis. Participants expressed a need for more comprehensive counseling and access to genetic testing, recognizing the added clarity it would bring to their families’ risk of cancer. Conclusion Improved communication from health care teams could clarify the risk of cancer for affected families. The introduction of affordable genetic testing and counseling for breast cancer in Kenya is welcomed by survivors.
APA, Harvard, Vancouver, ISO, and other styles
5

Selman, Carolina, Mabel Hurtado, Badir Chahuan, Fabiola Mella, and Hugo Marsiglia. "Prevalence of BRCA1 and BRCA 2 and other mutations in Chilean population." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e13553-e13553. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13553.

Full text
Abstract:
e13553 Background: Arturo López Pérez Foundation (FALP) is a Chilean Institution aimed to treatment of cancer patients. Since 2016 it has an Unit for Oncological Genetic Counseling (AGO) for patients with warning flags of potential cases of cancer of genetic origin AGO Unit is aimed to capture patients with warning flags and deliver information through pre-test counseling, offer possibility of a genetic test and post-test counseling. The purpose of this review is to provide relevant results of four years of this Unit. Methods: A descriptive study was carried out from patient care in the Oncological Genetic Counseling Unit of FALP between 2016 and 2019. It was considered those cases in which the process of pretest/post-test counseling was performed. Six "warningflags" were established: cancer in patients under 50 years of age, triple negative breast cancer, breast cancer in men, ovarian cancer, history of 2 or more primary cancers and a family history of cancer The number of test performed was analyzed. The results were expressed in positive pathogenic variants, uncertain variants and negative results. Results: 365 genetic counseling processes were carried out during the period. The average consultation age was 43.2 years (20.8 and 75.5) and 90.1% (329 attentions ) were female. Of the patients, 79.7% (294) perform the genetic test. 18.5% tested positive for a pathogenic variant, 6.5% for a pathogenic variant plus an uncertain variable, and 2.8% for two pathogenic variants. The mutations found were BRCA2 32.6% BRCA1 29.1%, ATM 10.1% RAD51C 6.7% CDKN2 A 5.6%, MUTYH 3.4% TP53 3.4%, MSH2 3.4% RAD51D 2.4%), NF1 1.1%, NTHL1 1.1%, RET 1.1% A 64.9% (237 patients) had cancer diagnosed at the time of the consultation, versus 33.1% of healthy care. 2% had no information. The type of cancer present was 79.7% breast cancer (189), 8.0% ovarian cancer, 2.1% thyroid cancer, 1.7% breast and ovarian cancer, 0.9% colon and/or endometrial cancer and 7.6% other cancers. The warning flags present were 41.2% age below 50 years, 26.2% family history, 15.4% relatives of people with positive results, 8.5% patients with triple-negative breast cancer, 5.3% patients with ovarian cancer, 2.8% patients with 2 or more primary cancers, and 0.6% male breast cancer patients. Conclusions: The highest percentage of patient care was for women with breast cancer, under 50 years of age. The overall test positivity rate is a cumulative 29%. Mutations in BRCA 1 and BRCA 2 were the most detected mutations, as reported in the literature. The slight predominance of BRCA 2 may be due to a familiar component. This is the largest report made in the Chilean population.
APA, Harvard, Vancouver, ISO, and other styles
6

Scheuer, Lauren, Noah Kauff, Mark Robson, Bridget Kelly, Richard Barakat, Jaya Satagopan, Nathan Ellis, et al. "Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers." Journal of Clinical Oncology 20, no. 5 (March 1, 2002): 1260–68. http://dx.doi.org/10.1200/jco.2002.20.5.1260.

Full text
Abstract:
PURPOSE: To prospectively determine the impact of genetic counseling and testing on risk-reduction strategies and cancer incidence in a cohort of individuals at hereditary risk for breast and ovarian cancer. PATIENTS AND METHODS: Two hundred fifty-one individuals with BRCA mutations were identified at a single comprehensive cancer center from May 1, 1995, through October 31, 2000. Uniform recommendations regarding screening and preventive surgery were provided in the context of genetic counseling. Patients were followed for a mean of 24.8 months (range, 1.6 to 66.0 months) using standardized questionnaires, chart reviews, and contact with primary physicians. RESULTS: Frequency of cancer surveillance by physical examinations and imaging studies increased after genetic counseling and testing. Twenty-one breast, ovarian, primary peritoneal, or fallopian tube cancers were detected after receipt of genetic test results. Among 29 individuals choosing risk-reducing mastectomy after testing, two were found to have occult intraductal breast cancers. Among 90 individuals who underwent risk-reducing salpingo-oophorectomy, one early-stage ovarian neoplasm and one early-stage fallopian tube neoplasm were found. Radiographic or tumor marker–based screening detected six breast cancers, five of which were stage 0/I, one early-stage primary peritoneal cancer, and three stage I or II ovarian cancers. Six additional breast cancers were detected by physical examination between radiographic screening intervals; four of these six tumors were stage I. No stage III or stage IV malignancies were detected after genetic testing. CONCLUSION: This study provides prospective evidence that genetic counseling and testing increased surveillance and led to risk-reducing operations, which resulted in diagnosis of early-stage tumors in patients with BRCA1 and BRCA2 mutations.
APA, Harvard, Vancouver, ISO, and other styles
7

Cohen, Stephanie A., and Dawn Nixon. "Abstract P2-09-18: Use of navigators to identify breast cancer patients for genetic counseling and testing: A quality improvement project." Cancer Research 82, no. 4_Supplement (February 15, 2022): P2–09–18—P2–09–18. http://dx.doi.org/10.1158/1538-7445.sabcs21-p2-09-18.

Full text
Abstract:
Abstract The value of genetic counseling and testing to cancer prevention, early detection, and treatment options to ensure optimal outcomes is widely acknowledged by providers, payers and patients. However, many individuals who should receive genetic counseling are never offered this service. All patients with early onset (&lt;=age 45), triple negative (&lt;=60) and metastatic HER2 negative breast cancer should be offered genetic counseling and testing (GC/GT) per National Comprehensive Cancer Network guidelines. A quality improvement project to actively identify and offer genetic counseling to all women with early onset, triple negative and metastatic breast cancer was implemented.Baseline information on the number of early onset (&lt;=45), triple negative and metastatic HER2 negative breast cancers diagnosed January 2018-June 2019 was collected and cross-referenced with the Cancer Genetics Risk Assessment patient database and the electronic health record (EHR) to see how many had GC/GT in our department or the breast surgeons’ office. We developed questions for an electronic screening tool used by the navigation team when meeting with patients for the first time, screening for personal or family history criteria that would flag patients at increased risk for hereditary cancer. If any questions were flagged, the patient was asked by the navigator if they would be interested in a genetic counseling appointment to consider genetic testing. Training was provided to the navigation team so that they could answer basic questions, bi-weekly meetings were set up to discuss patients, and a flier and informational videos were made available to patients who wanted more information about GC/GT. If a patient was agreeable to genetic counseling, an automated email was triggered to the genetics team, who contacted the patient for an appointment. A standing order was obtained from willing breast surgeons and oncologists within our network to streamline the referral process. In the 18-month baseline period, there were 126 patients diagnosed with early onset, 36 with triple negative &lt;=60 and 30 with metastatic HER2 negative breast cancer. Of these, 57.1% of early onset, 66.7% triple negative and 3.3% of those with metastatic breast cancer had documentation of GC/GT. A paper screening tool was implemented in July 2019 with implementation of an electronic version in November 2019. In the 18-month intervention period, there were 100 patients diagnosed with early onset, 39 with triple negative and 22 patients with metastatic breast cancer. Of these, 86% of early onset, 87.2% of triple negative and 31.8% of metastatic breast cancer patients had documented GC/GT.A limitation of this project is that some patients leave the system to be treated elsewhere after diagnosis and some may have been tested in their private practitioner’s office that does not connect with our EHR. Additionally, some may have been offered GC/GT but declined or were unwilling/unable to complete an appointment. Finally, the pandemic likely had an impact on this project, since fewer women were undergoing mammography screening due to COVID-19 restrictions, resulting in fewer diagnoses of breast cancer. By leveraging the navigation team’s interaction with breast cancer patients, we were able to improve identification and referral of more patients with early onset, triple negative &lt;=60 and metastatic HER2 negative breast cancer for GC/GT. One barrier to genetic counseling that has been previously identified is a lack of physician referral. Active engagement with a breast navigator can circumvent this barrier. De-identified aggregate data from this quality improvement project was shared with the Association for Community Cancer Centers as part of a larger project, supported by a grant from Pfizer. Citation Format: Stephanie A. Cohen, Dawn Nixon. Use of navigators to identify breast cancer patients for genetic counseling and testing: A quality improvement project [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P2-09-18.
APA, Harvard, Vancouver, ISO, and other styles
8

Szender, J. Brian, Jasmine Kaur, Katherine Clayback, Mollie L. Hutton, June Mikkelson, Kunle Odunsi, and Cara Dresbold. "Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer." International Journal of Gynecologic Cancer 28, no. 1 (January 2018): 26–33. http://dx.doi.org/10.1097/igc.0000000000001122.

Full text
Abstract:
ObjectiveThe aim of this study was to evaluate the ability of patients at risk of hereditary breast and ovarian cancer (HBOC) syndrome to select the extent of genetic testing personally preferred and the impact of demographic factors on the breadth of testing pursued.MethodsA single-institution cohort was enumerated consisting of patients referred for clinical genetic counseling secondary to risk of HBOC syndrome. This was a retrospective study of consecutive patients seen for genetic counseling; all patients completed an epidemiologic questionnaire and provided personal and family medical histories. Patients meeting guidelines for testing were offered testing at 3 levels: single gene/condition (Single), small panels with highly penetrant genes (Plus), and large panels with high and moderately penetrant genes (Next). Associations between personal or family-related factors and breadth of testing selected were investigated. Continuous and categorical variables were compared using Student t and χ2 tests, as appropriate. Joint classification tables were used to test for effect modification, and a log-binomial model was used to compute rate ratios (RR) with a threshold of P < 0.05 considered significant.ResultsWe identified 253 patients who underwent genetic counseling for HBOC syndrome. Most patients were personally affected by cancer (63.6%), reported at least some college (79.2%), met the National Comprehensive Cancer Network guidelines for BRCA testing (94.5%), and opted to undergo genetic testing (94.1%). Most (84.9%) patients opted for panel testing. An increased likelihood of choosing Next-level testing was found to be associated with patients having any college experience (RR, 1.53; 95% confidence interval, 1.02–2.30), as well as being unaffected by cancer (RR, 1.30; 95% confidence interval, 1.03–1.64).ConclusionsClinical genetic counseling is a highly specialized service, which should be provided to patients at risk of hereditary cancer syndromes. Although some epidemiologic factors can predict a patient's preference for testing breadth, patients were sufficiently able to self-identify the level of testing they were comfortable with after receiving genetic counseling. Most practitioners do not have the time or expertise to provide the degree of counseling needed to enable and empower patients to choose the level of testing they are comfortable with. When available, referral to genetic counselors remains an important component of comprehensive care for women with a personal or family history of cancer suggestive of hereditary risk.
APA, Harvard, Vancouver, ISO, and other styles
9

Neviere, Zoé, Thibault De La Motte Rouge, Anne Floquet, Alison Johnson, Pascaline Berthet, and Florence Joly. "How and when to refer patients for oncogenetic counseling in the era of PARP inhibitors." Therapeutic Advances in Medical Oncology 12 (January 2020): 175883591989753. http://dx.doi.org/10.1177/1758835919897530.

Full text
Abstract:
Poly(ADP-ribose)polymerase (PARP) inhibitors are targeted therapy for cancers with homologous repair deficiency (HRD). They were first approved for ovarian cancer and have changed current treatment strategies. They have also demonstrated efficacy in HER2-negative metastatic breast cancer and advanced prostate cancer with BRCA1/2 or ATM mutations. Patients with somatic and/or germline BRCA1/2 mutations benefit more from these treatments than other patients. Nowadays, the diagnosis of HRD is largely based on germline genetic testing, which is performed after an in-person genetic counseling session, even for patients without any family history of cancer. However, with the increasing number of PARP inhibitor indications across different tumor types, rapid access to oncogenetic consultations will become a challenge. To meet this demand, tumor genomic testing could be offered at initial diagnosis. Telephone counseling and other referral systems could replace in-person consultations for certain subgroups of patients deemed to have a low risk of harboring a germline mutation. This article reviews international guidelines for genetic counseling testing. We herein propose new care pathways for breast, prostate and ovarian cancers, including tumor genomic testing at initial diagnosis in order to help triage genetic counseling referrals.
APA, Harvard, Vancouver, ISO, and other styles
10

Brown, Jubilee, Aly Athens, David L. Tait, Erin K. Crane, Robert V. Higgins, R. Wendel Naumann, Lejla Hadzikadic Gusic, and Lisa Amacker-North. "A Comprehensive Program Enabling Effective Delivery of Regional Genetic Counseling." International Journal of Gynecologic Cancer 28, no. 5 (June 2018): 996–1002. http://dx.doi.org/10.1097/igc.0000000000001256.

Full text
Abstract:
ObjectivesThe aim of this study was to demonstrate the utility of a comprehensive program involving management-based evidence, telemedicine, and patient navigation to provide genetic counseling services for patients with ovarian and breast cancer across a geographically large health care system.MethodsWe identified all patients with newly diagnosed ovarian and breast cancer in our health care system from January 2013 to December 2015 through the cancer registry. Referral characteristics and testing outcomes were recorded for each year and compared using the χ2 or Fisher exact test.ResultsBecause the implementation of this program, the number of new ovarian cancer cases remained constant (109–112 cases/year) but patients referred for genetic counseling increased annually from 37% to 43% to 96% (P < 0.05). The percentage of ovarian cancer patients who underwent genetic testing increased annually from 24% to 27% to 53% (P < 0.05). The number of new breast cancer patients was constant (1543–1638 cases/year). The percentage of patients with triple negative breast cancer referred for genetic counseling rose from 69% in 2013 to 91% in 2015; the percentage of patients who underwent testing increased annually from 59% to 86% (P < 0.05). Of women with breast cancer diagnosed at less than 45 years of age, 78% to 85% were referred for genetic counseling across this period; the percentage of patients who underwent testing increased annually from 66% to 82% (P < 0.05). Patient navigation was initiated and was available to all patients in the system during this period. Telemedicine consults were performed in 118 breast/ovarian patients (6%) during this period.ConclusionsA comprehensive program may improve access to effective genetic counseling services in patients with ovarian and breast cancer despite geographic barriers.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Breast Cancer Patients Counseling of"

1

Radcliffe-Branch, Deborah S. "The contribution of interactive health communication (IHC) and constructed meaning to psychosocial adjustment among women newly diagnosed with breast cancer /." Thesis, McGill University, 2005. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=85956.

Full text
Abstract:
This doctoral dissertation, as part of a large and ongoing CIHR-funded study, used a subset of the total sample to evaluate the contribution of interactive health communication (IHC) as a complement to more traditional means of informational support (Care-as-usual) to optimal adjustment of women newly diagnosed with breast cancer (N = 135). According to the study protocol, participants in the experimental group received an IHC educational intervention for an eight-week period. Measures of psychosocial adjustment and information-related variables were administered in interviews at Time 1 (pre-intervention) within 8 weeks of initial diagnosis, and again 8 weeks post-intervention (Time 2). Psychosocial adjustment variables included: depressive symptoms (CESD), anxiety (STAI-Y), well-being (IWB), and quality of life (SF-36)-mental and physical health components. Information-related variables included: the need for information related to cancer, cancer-specialist, and family or friend's informational support, and overall satisfaction with information. Optimism and Constructed meaning were evaluated at Time 1 and 2, respectively. A GLM MANCOVA model tested overall F-ratios and regression coefficients using difference scores. Predictors in the model were: group (experimental versus control), constructed meaning, and optimism. The overall model (df = 8, 121) was significant for Group, F = 3.66, p < .001, effect size eta2 = .20, Constructed Meaning, F = 3.04, p < .004, effect size eta2 = .17, and Optimism, F = 2.95, p < .005, effect size eta2 = .16. Participants in the dissertation experimental group had significant improvements in QOL-physical health and overall satisfaction with information when compared with the control group. Constructed meaning was significantly associated with beneficial changes in all of the adjustment-related variables. The results of this dissertation clarify the potentially significant roles IHC and constructed meaning pl
APA, Harvard, Vancouver, ISO, and other styles
2

Kyei, Kofi Adesi. "Assessment of Anxiety and Depression Among Breast Cancer Patients Undergoing Treatment in Ghana." ScholarWorks, 2017. https://scholarworks.waldenu.edu/dissertations/4526.

Full text
Abstract:
Breast cancer patients undergoing radiotherapy often experience severe levels of anxiety and depression. There is a gap in the research literature from Africa, particularly from Ghana, with few studies focusing on the assessment of anxiety and depression among breast cancer patients undergoing radiation treatment. A better understanding was essential to promote efforts to help breast cancer patients cope with their diagnosis and treatment and increase their overall quality of life. This mixed method study examined breast cancer patients in Ghana undergoing radiotherapy and their responses related to anxiety and depression through a concurrent triangulation involving an interview with selected professional participants and a detailed patient survey. Patients completed 2 modified scales, the Patient Health Questionnaire and Depression Anxiety Stress Scale. The sample consisted of 100 patients between the ages of 20-89. Individual interviews were held with 6 professionals with a minimum of 5 years of work experience. Themes were generated through open coding of the interview data, while multiple regression was performed to determine the relationship between depression and anxiety with the independent variables . Findings of this study indicated the need intervene through counseling and education on behalf of patients in Ghana as they undergo breast cancer treatment. Age and monthly income of patients were statistically significant in predicting the anxiety and depression among the patients. The study's implications will lead to positive change when all stakeholders take on the responsibility of implementing measures to promote coping strategies for breast cancer patients in Ghana.
APA, Harvard, Vancouver, ISO, and other styles
3

Ferlatte, Christy. "Patient preferences for an appropriate time for cancer genetic counseling and BRCA testing for women diagnosed with breast cancer." Waltham, Mass. : Brandeis University, 2009. http://dcoll.brandeis.edu/handle/10192/23193.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Coltri, Julia Anne. "Transgender male patients and hereditary breast cancer risk: broaching difficult topics to reduce healthcare disparities." The Ohio State University, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1555683611281611.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Alsulaiman, Reem Jawad. "Exploring women's experiences with breast cancer and the effectiveness of psychotherapeutic interventions in relation to mental wellbeing and treatment compliance in patients residing in the state of Qatar." Thesis, Regent's University London, 2017. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.738185.

Full text
Abstract:
Introduction: An insufficient number of studies have been carried out in the Middle East exploring the variables that contribute to breast cancer patients’ psychological distress. In addition, very few studies exist that evaluate the role of structured psychotherapeutic interventions in enhancing breast cancer patients’ psychological well-being and quality of life. This study has been designed to address this limitation by conducting a mixed-method approach to explore women’s experiences with the diagnosis of breast cancer and with two structured psychotherapeutic interventions, namely, ‘crisis counselling’ and ‘psycho-education’. Methods: A total of 201 women with early stage breast cancer from the State of Qatar were recruited and randomised into either the control group or one of the treatment groups (crisis counselling and psycho-education). The aim of the quantitative approach was to evaluate the short- and long-term benefits of the crisis counselling and psycho-education interventions, in terms of improving patients’ psychological well-being, quality of life and treatment compliance. This was achieved by asking all patients to complete the DASS21 and QLQ-C30 instruments at different points in time and by monitoring their compliance with treatment. Later, a qualitative approach was utilised: twelve Arab patients from the treatment groups were invited to attend focus-group interviews in order to explore their experience with the diagnosis of breast cancer and with the study interventions. Results: the qualitative results of this study revealed that fear of social stigma, difficulty coping with fatigue and body image changes, and altered intrafamilial/sexual relationships contribute significantly to Arab women’s psychological distress. The quantitative results revealed that both of the study interventions were effective in improving women’s psychological well-being and quality of life over time but had no impact on patients’ compliance with treatment. In addition, the study showed that psycho-education conferred a greater advantage than did the crisis counselling model, especially on improving women’s psychological well-being over time. Conclusion: The results of this study will significantly aid health care professionals in the State of Qatar to improve the care of breast cancer patients, through awareness-raising education about the disease and its associated social stigma and by initiating changes to the psychotherapeutic services through the implementation of crisis counselling and psycho-education interventions in the future.
APA, Harvard, Vancouver, ISO, and other styles
6

Grobbelaar, Frederik Russouw. "Die invloed van 'n mastektomie op die man-vrou verhouding : 'n pastorale ondersoek." Thesis, Stellenbosch : Stellenbosch University, 1993. http://hdl.handle.net/10019.1/19405.

Full text
Abstract:
Thesis (MTh)--Stellenbosch University, 1993
ENGLISH ABSTRACT: Seeing that breast cancer is the most common cancer in women and that it has such a high incidence that every woman should be aware of it, time has come for the theology, and especially for pastoral care, to provide some answers on the possible problems that accompany the illness. Treatment of breast cancer almost always include a degree of surgical intervention through which part of or a whole breast, and in extreme cases even the underlying tissue, is being removed. This procedure, to some extent, influences a woman's experience of her physique which in turn has an effect on the intimate space of her marriage. The mastectomy patient may experience that the operation, with all the psychological affects it has, disturbs her inner life rythm and that results in her relationships also being pressurised. The crisis of a mastectomy should be handled as a relationship crisis within a marriage, in which the husband can play an important therapeutic role. The husbands contribution will be greatly effected by: a) His commitment to the relationship and b) The correlation between his male identity, his sexuality and his perceptions of the female physique. Within the crisis of mastectomy, the woman's body-image should not be separated from her faith identity and the quality of her marriage - there exists a dynamic interaction between these three, which means that the handling of the crisis of a mastectomy is directly dependent on the quality if her loving relationship and on the way in which she experiences her faith. The faith factor plays an important role in the handling of the crisis, by creating a distance between the trauma of the loss and the way in which she experiences her identity. Pastoral care can play a vital role in the handling of the crisis of a mastectomy by means of guidance and support, as it proclaims the active presence of God through the marrid body of Jesus Christ. The husband of the mastectomy patient can, in his therapeutic role, be guided to be much more sensitive for the emotional needs of his wife, in regard to aspect of sexuality. This would give her the support she needs and work constructively towards the goal of healing.
AFRIKAANSE OPSOMMING: Aangesien borskanker die algemeenste kanker onder vroue is en dit sulke geweldige afmetings aangeneem het dat elke vrou daarmee moet rekening hou, het dit tyd geword dat die teologie, en met name die pastoraat, ditself ook ten opsigte van die moontlike problematiek wat daarmee saamgaan, moet verantwoord. Die behandeling van borskanker behels in die meerderheid van gevalle 'n mate van chirurgiese ingrepe waardeur 'n deel van of die hele bors, en in ekstreme gevalle ook die onderliggende weefsel, verwyder word. Hierdie prosedure oefen, in 'n mindere of meerdere mate, 'n invloed op die vrou se belewing van haar liggaamlikheid uit wat weer na die intieme band van die huwelik kan deurwerk. Die mastektomiepasiënt kan ervaar dat die operasie, met al die sielkundige effekte wat dit inhou, haar innerlike lewensritme versteur sodat die verhoudinge waarin sy leef ook onder druk geplaas word. Binne die huwelik sou 'n mens dan die krisis van 'n mastektomie as 'n verhoudingskrisis moet hanteer, waarin die eggenoot 'n belangrike terapeutiese funksie kan vervul. Die man se bydrae word egter deurslaggewend bepaal deur: a) Sy verbintenis aan die verhouding en b) Die korrelasie tussen sy manlike identiteit, seksualiteit en die persepsies met betrekking tot die liggaamlikheid van die vrou. Binne die krisis van 'n mastektomie kan die vrou se liggaamsbeeld nie van haar geloofsidentiteit en die kwaliteit van haar huwelik losgemaak word nie - hierdie drie staan in 'n interdinamiese verband en beteken dat die verwerking van die krisis van 'n mastektomie direk van die kwaliteit van die liefdesverhouding en die ervaring van geloof, afhang. In die verwerking van die krisis vervul die geloofsfaktor 'n deurslaggewende rol om afstand tussen die emosionele trauma van die verlies en die ervaring van identiteit te skep. Die pastoraat kan 'n belangrike funksie vervul ten opsigte van begeleiding en ondersteuning in die verwerking van die krisis van 'n mastektomie deurdat dit God se aktiewe betrokkenheid by die situasie, aan die hand van die liggaamlikheid van Jesus Christus, verkondig. As terapeut kan die eggenoot begelei word om, op die gebied van die seksuele, baie sterker op die emosionele behoeftes van die mastektomiepasiënt ingestel te wees, om haar sodoende te ondersteun en in die proses van heling mee te werk.
APA, Harvard, Vancouver, ISO, and other styles
7

Dasch, Kimberly B. "Affective differentiation in breast cancer patients." Access to citation, abstract and download form provided by ProQuest Information and Learning Company; downloadable PDF file, 70 p, 2009. http://proquest.umi.com/pqdweb?did=1885670961&sid=7&Fmt=2&clientId=8331&RQT=309&VName=PQD.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lagergren, Jakob. "Immediate breast reconstruction with implants in breast cancer patients /." Stockholm, 2007. http://diss.kib.ki.se/2007/978-91-7357-230-9/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yeung, Shuk-chong Rene. "Self-evaluation of coping resources of cancer patients /." Hong Kong : University of Hong Kong, 1999. http://sunzi.lib.hku.hk/hkuto/record.jsp?B22330914.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cheng, Wing-ming Edward. "Emotional well-being in Chinese lung cancer patients." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B3197157X.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Breast Cancer Patients Counseling of"

1

Siegel, Mary-Ellen. Breast cancer today: A guide for breast cancer patients and those who care about them. New York, NY: Chemotherapy Foundation, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Diagnosis, breast cancer: The best action plan for navigating your journey. Rolling Meadows, IL: Windy City Publishers, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

L, Scott Jennifer, ed. Helping couples cope with women's cancers: An evidence-based approach for practitioners. New York: Springer, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Høybye, Mette Terp. Storytelling of breast cancer in cyberspace: On line counteractions to the isolation and demeaning of illness experience. Copenhagen: University of Copenhagen, Videnskabsbutikken, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ellis, Alda. Beyond breast cancer. Eugene, Or: Harvest House, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Colmore, Perry. Living with breast cancer. Andover, Mass: Andover Townsman, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Breast cancer: Taking control. Sydney, Australia: Boycare Publishing, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chart, Pamela. Breast cancer: A guide for patients. Toronto: Prospero Books, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kneece, Judy C. Your breast cancer treatment handbook. 2nd ed. Columbia, South Carolina: EduCare Pub., 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Canadian Breast Cancer Research Initiative. Canadian Breast Cancer Initiative guidelines for the care & treatment of breast cancer. [Ottawa]: Health Canada, Canadian Breast Cancer Initiative, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Breast Cancer Patients Counseling of"

1

Dinas, Konstantinos D. "Fertility Counseling and Preservation for Breast Cancer Patients." In Advances in Experimental Medicine and Biology, 181–87. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-41596-9_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Condorelli, Margherita, and Matteo Lambertini. "Fertility and Pregnancy Counseling of Breast Cancer Patients with Germline BRCA Mutations." In Fertility Challenges and Solutions in Women with Cancer, 131–47. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-24086-8_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Truong, Anne N. "Rehabilitation of Patients with Breast Cancer." In Breast Cancer, 430–51. New York, NY: Springer New York, 2001. http://dx.doi.org/10.1007/978-0-387-21842-7_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Damato, Bertil E. "Counseling Patients with Cancer." In Clinical Ophthalmic Oncology, 161–71. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-04489-3_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hope-Stone, Laura, and Bertil Damato. "Counseling Patients with Cancer." In Clinical Ophthalmic Oncology, 133–40. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-40489-4_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gianni, Lorenzo, Alessandra Affatato, and Davide Tassinari. "Follow-Up of Patients with Breast Cancer." In Breast Cancer, 769–78. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-48848-6_65.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ramirez, Pedro T., and Ralph S. Freedman. "Gynecologic Problems in Patients with Breast Cancer." In Breast Cancer, 382–405. New York, NY: Springer New York, 2001. http://dx.doi.org/10.1007/978-0-387-21842-7_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fornage, Bruno D. "Role of Sonography in Patients with Breast Cancer." In Breast Cancer, 18–52. New York, NY: Springer New York, 1999. http://dx.doi.org/10.1007/978-1-4612-2146-3_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gwyn, Karin M., and Richard L. Theriault. "Special Clinical Situations in Patients with Breast Cancer." In Breast Cancer, 406–29. New York, NY: Springer New York, 2001. http://dx.doi.org/10.1007/978-0-387-21842-7_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Baines, Joanna. "Three Stories: Generations of Breast Cancer." In Cancer Patients, Cancer Pathways, 13–35. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Breast Cancer Patients Counseling of"

1

"Case series: Breast and ovarian cancer syndrome." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685364.

Full text
Abstract:
Aims and Objectives: To report a series of cases with breast and ovarian carcinomas either in same patient or in a family and identifying the importance of BRCA 1, 2 genetic testing in such individuals. Materials and Methods: The medical records of breast and ovarian cancer patients operated over past 3 years at a single institute were reviewed retrospectively and their clinical profile, family history, final pathological reports and follow up data was collected. Results: 8 patients were found to have breast and ovarian malignancies, out of which 3 had synchronous breast and ovarian cancers, 4 had metachronous and 1 patient with ovarian cancer had history of breast cancer in family. Median age of presentation to the hospital was 47 years and median time interval in metachronous disease patients was 5.5 years. Conclusion: About 5% of people who have breast cancer and about 10% of women who have ovarian cancer have HBOC, caused by germline mutation in BRCA 1, 2 gene. These individuals have increased risk of developing breast cancer at younger age, TNBC, or developing a second primary in breast or ovary plus an overall risk of breast/ovarian/prostate/pancreatic malignancies in other family members due to inheritable mutation. Identification of BRCA mutation in such individuals can help family members to undergo genetic counseling and follow different screening and prevention guidelines from general population thus reducing the cancer risks.
APA, Harvard, Vancouver, ISO, and other styles
2

"Case series: Breast and ovarian cancer syndrome." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685348.

Full text
Abstract:
Aims and Objectives: To report a series of cases with breast and ovarian carcinomas either in same patient or in a family and identifying the importance of BRCA 1,2 genetic testing in such individuals. Materials and Methods: The medical records of breast and ovarian cancer patients operated over past 3 years at a single institute were reviewed retrospectively and their clinical profile, family history, final pathological reports and follow up data was collected. Results: 8 patients were found to have breast and ovarian malignancies, out of which 3 had synchronous breast and ovarian cancers, 4 had metachronous and 1 patient with ovarian cancer had history of breast cancer in family. Median age of presentation to the hospital was 47 years and median time interval in metachronous disease patients was 5.5 years. Conclusion: About 5% of people who have breast cancer and about 10% of women who have ovarian cancer have HBOC, caused by germline mutation in BRCA1, 2 gene. These individuals have increased risk of developing breast cancer at younger age, TNBC, or developing a second primary in breast or ovary plus an overall risk of breast/ovarian/prostate/pancreatic malignancies in other family members due to inheritable mutation. Identification of BRCA mutation in such individuals can help family members to undergo genetic counseling and follow different screening and prevention guidelines from general population thus reducing the cancer risks.
APA, Harvard, Vancouver, ISO, and other styles
3

Kuroda, Flávia, Cicero Andrade Urban, Marcelo Paula Loureiro, Mateus Ricardo Ulsan Lourenço, and Bernardo Passos Sobreiro. "A PROSPECTIVE EVALUATION OF BREAST SATISFACTION AND EXPECTATION IN PREOPERATIVE BREAST RECONSTRUCTION PATIENTS." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1092.

Full text
Abstract:
Introduction: There is a consensus that breast reconstruction makes an important positive contribution to the quality of life of breast cancer patients. However, a large proportion of breast cancer survivors have unmet expectations surrounding reconstruction after mastectomy, particularly in relation to appearance. Approximately 40% of women who underwent breast reconstruction after mastectomy reported their reconstruction to be worse than expected. There is little consensus about what impact specific factors have on women`s satisfaction with breast reconstruction process and outcomes. Objectives: To delineate factors affecting preoperative native breast satisfaction and expectation with the surgery using the BREAST-Q in patients prior to oncological breast surgery following breast reconstruction. Methods: A prospective cross-sectional trial with breast cancer patients enrolled from November 2019 to December 2020 at Hospital Nossa Senhora das Graças Breast Unit in Curitiba, Brazil. Two independent groups were studied. The first group included patients who underwent mastectomy following immediate breast reconstruction (IBR) with implant. The second group underwent breast-conserving therapy (BCT) following level 2 oncoplastic techniques. This study was approved by the Internal Review Boad of Positivo University, Curitiba, Brazil. All patients were invited to complete a patient-reported outcome (BREAST-Q) Expectations Module and Pre-operative Breast reconstruction module prior to surgery. Results: Overall, seventy-nine patients with breast cancer completed the preoperative BREAST-Q. Patients were divided into BCT following oncoplastic surgery (n=49) and mastectomy following IBR with implant (n=30) groups. The mastectomy with IBR implants group had better satisfaction with their native breast than BCT oncoplastic group. Comparing Breast-Q expectations rate, women in BCT following oncoplastic group had higher expectations for breast appearance when clothed than the group of mastectomy with IBR implant. Previous aesthetic breast surgery and neoadjuvant chemotherapy were significant predictors of preoperative physical well-being. Younger age was significantly correlated with pain expectation in the surgery. Patients who were fifty years old or more and had a university or higher education level expected that the breast appearance would match almost as well as the same ten years after. Conclusions: This study results highlight the need to improve education and informed decision-making about breast reconstruction. Patients demonstrated to have high expectations for breast appearance after reconstruction and expect not to change over time. Understanding which factors affect patient’s satisfaction with native breasts and their expectation with the surgery in the preoperative set could improve preoperative counseling and the management of patient’s expectations of subsequent breast reconstruction.
APA, Harvard, Vancouver, ISO, and other styles
4

Reis, Gabriel Baêta Branquinho, Hugo Francisco da Fonseca Neto, Alice Jardim Zaccariotti, Daniel Bispo de Sousa, Silvaleide Ataides Assunção, Thiago Martins de Abreu, Fernando Santos de Azevedo, and Lanúscia Morais de Santana. "INVASIVE DUCTAL CARCINOMA IN A PATIENT WITH LI-FRAUMENI SYNDROME: A CASE REPORT." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2105.

Full text
Abstract:
Introduction/Objectives: Breast cancer is one of the most common malignancies among women, with 10% resulting from genetic predisposition. Li-Fraumeni syndrome is an autosomal dominant disease that predisposes to multiple primary tumors and is responsible for less than 0.1% of breast cancers, being considered in early-onset tumors. The aim of this report was to describe a fast evolution of three primary tumors in a young patient with Li-Fraumeni syndrome, including ductal breast carcinoma. Case Report: In 2017, a 27-year-old female patient was diagnosed with malignant cancer of the right breast, Luminal HER KI67 70%, clinical stage IV (liver and lung), underwent first-line cancer treatment, maintaining endocrinotherapy and Double Block, with a positive genetic panel test for TP53 mutation, inferring SLF. In 2018, screening colonoscopy showed colon adenocarcinoma, pT53pN1, treated with total colectomy with ileal pouch, followed by suspension of endocrinotherapy and maintenance of Double Block and adjuvant FOLFOX. At the end of chemotherapy, endocrinotherapy was adopted again. Reassessment tests showed partial response in the liver, but the primary nodules were unchanged. Biopsy after thoracoscopy described lung adenocarcinoma, pT3pN2, submitted to adjuvant with Gemzar and Navelbine, followed by Double Block and interruption of endocrinotherapy. It evolved with the appearance of nodules in the right breast, suggestive of progression of breast disease, under treatment with Xeloda, Herceptin, and Perjeta, showing good clinical response. Discussion: Breast cancer in young people increases the possibility of heredity, thus raising the need for investigations of genetic syndromes. Although rare, the identification of FHL brings an important implication for the genetic counseling. Early diagnosis is the best form of management, enabling the preventive screening and intervention of multiple malignancies. Conclusion: Cases of breast cancer in young women should raise a suspected diagnosis of Li-Fraumeni syndrome, which can change the therapeutic and investigation of other cancers at an early stage.
APA, Harvard, Vancouver, ISO, and other styles
5

Weldon, Christine B., Julia R. Trosman, Danielle M. Dupuy, Betty Roggenkamp, Pamela Ganschow, Julian C. Schink, and Anne Marie Murphy. "Abstract A38: Are breast cancer screening patients with family cancer history directed to genetic counseling/testing?" In Abstracts: AACR International Conference on the Science of Cancer Health Disparities‐‐ Sep 18-Sep 21, 2011; Washington, DC. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1055-9965.disp-11-a38.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Heinzen, Rebeca Neves, Maria Eduarda Meyer, Liliane Raupp Gomes Pizatto, and Adriana Magalhães de Oliveira Freitas. "PREVALENCE OF VARIANTS OF UNCERTAIN SIGNIFICANCE IN TESTS REQUESTED FOR BREAST CANCER PATIENTS IN A PRIVATE SERVICE." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1049.

Full text
Abstract:
Introduction: The genetic mutations test among breast cancer (BC) patients is one of the steps for the diagnosis in the majority of the patients. To identify and manage patients with hereditary predisposition to cancer is also a competence of the breast surgeon. The development of Next Generation Sequence (NGS) has allowed the reduction of the tests’ cost as well as the expansion of the analyzed genes, besides BRCA 1 and 2, and the inclusion of new genes of high and moderate penetrance. There is a concern about the impact of these results because there is not a well-established conduct for all the mutations as well as for the increase of the diagnoses of variant of uncertain significance (VUS) diagnosed in the panels, mostly in patients that did not receive a formal genetic counseling. Studies show that the larger number of analyzed genes is related to a better chance of detecting VUS, reaching 40%, but they are not conduct modifiers. The literature shows that approximately 90% of VUS are reclassified as benign. Objectives: To assess prevalence of VUS in multigenic panels requested by the non-geneticist physician, in private office, performed on patients with BC diagnosis. Methods: A retrospective cross-sectional study was conducted based in data from invasive BC patients or in situ or with high risk for neoplasia that attended a private office and were subjected to multigenic panels requested by the non-geneticist physician from January 2019 to January 2020. Statistical analysis frequency measurements were analyzed in Excel Office®. Results: 147 patients underwent the genetic test of 83 genes with NGS technology. Only one was a male. Among the tests performed, 48 were negative for pathogenic variants and 23 were positive for pathogenic mutations in 22 (15%) patients, the most common being in BRCA2 gene (7 cases), followed by MUTHY (6 cases). 137 VUS occurred in 77 (52.4%) patients, the most common of these being in gene POLE and RECQL4. Conclusions: The data found in our population match the literature, showing more than half of the patients with VUS. This demonstrates the importance of test interpretation as well as inpatient correct orientation.
APA, Harvard, Vancouver, ISO, and other styles
7

Abdel-Razeq, Hikmat, Lama Abujamous, Amal Al-Omari, Abdelghani Tbakhi, and Dima Jadaan. "Abstract P2-09-06: Genetic counseling and genetic testing for germline BRCA1/2 mutations among high risk breast cancer patients in Jordan: A study of 500 patients." In Abstracts: 2019 San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.sabcs19-p2-09-06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Katz, SJ, M. Morrow, R. Jagsi, and A. Kurian. "Abstract P2-02-06: Genetic counseling, germline genetic testing, and impact of results in patients with newly diagnosed breast cancer." In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-p2-02-06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sohn, Ji Yeon, Boyoung Park, Kyong-Ah Yoon, Soo Jin Park, Moo Hyun Lee, Eun Hae Cho, Keun Seok Lee, Myong Cheol Lim, Sun-Young Kong, and Eun Sook Lee. "Abstract 3474: Prevalence ofBRCA1andBRCA2small mutation and large genomic rearrangements in breast cancer patients visiting a genetic counseling clinic." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-3474.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wevers, MR, MG Ausems, EM Bleiker, EJ Rutgers, AJ Witkamp, DE Hahn, T. Brouwer, et al. "Abstract P4-11-01: Rapid genetic counseling and testing in newly diagnosed breast cancer patients, findings from an RCT." In Abstracts: Thirty-Fifth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 4‐8, 2012; San Antonio, TX. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/0008-5472.sabcs12-p4-11-01.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Breast Cancer Patients Counseling of"

1

Hughes, Chanita. Genetic Counseling for Breast Cancer Susceptibility in African American Women. Fort Belvoir, VA: Defense Technical Information Center, February 2005. http://dx.doi.org/10.21236/ada433977.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hughes, Chanita M. Genetic Counseling for Breast Cancer Susceptibility in African American Women. Fort Belvoir, VA: Defense Technical Information Center, February 2003. http://dx.doi.org/10.21236/ada413817.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hughes, Chanita M. Genetic Counseling for Breast Cancer Susceptibility in African American Women. Fort Belvoir, VA: Defense Technical Information Center, February 2004. http://dx.doi.org/10.21236/ada425772.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hughes, Chanita. Genetic Counseling for Breast Cancer Susceptibility in African American Women. Fort Belvoir, VA: Defense Technical Information Center, September 2007. http://dx.doi.org/10.21236/ada475548.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Novinger, Leah. Identification of Autoantibodies to Breast Cancer Antigens in Breast Cancer Patients. Fort Belvoir, VA: Defense Technical Information Center, October 2011. http://dx.doi.org/10.21236/ada555908.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Schnall, Mitchell D. MRI-Based Screen for Breast Cancer Patients Carrying a Breast Cancer Susceptibility Gene. Fort Belvoir, VA: Defense Technical Information Center, October 1997. http://dx.doi.org/10.21236/ada338681.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Schnall, Michael D. MRI-Based Screen for Breast Cancer Patients Carrying a Breast Cancer Susceptibility Gene. Fort Belvoir, VA: Defense Technical Information Center, October 1998. http://dx.doi.org/10.21236/ada359858.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Schnall, Mitchell D. MRI-Based Screen for Breast Cancer Patients Carrying a Breast Cancer Susceptibility Gene. Fort Belvoir, VA: Defense Technical Information Center, October 1999. http://dx.doi.org/10.21236/ada390928.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Farria, Dione M. Education and Outreach for Breast Imaging and Breast Cancer Patients. Fort Belvoir, VA: Defense Technical Information Center, July 2002. http://dx.doi.org/10.21236/ada407789.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Farria, Dione M. Education and Outreach for Breast Imaging and Breast Cancer Patients. Fort Belvoir, VA: Defense Technical Information Center, July 2003. http://dx.doi.org/10.21236/ada420124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Breast Cancer Patients Counseling of' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography